Aarey Drugs & Pharmaceuticals Limited

NSE:AAREYDRUGS.NS

66.39 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 3,956.1794,142.5294,916.0973,478.8853,000.8883,547.0523,486.3393,959.672,460.2872,134.4141,997.251,723.0741,304.807676.808465.03275.312250.501
Cost of Revenue 3,843.154,038.4074,720.6493,377.9022,901.8163,409.7283,373.6393,829.8822,430.2912,102.6661,963.3661,688.5171,276.083654.214452.267247.645231.805
Gross Profit 113.029104.122195.447100.98299.073137.324112.7129.78929.99631.74833.88434.55828.72422.59312.76327.66718.696
Gross Profit Ratio 0.0290.0250.040.0290.0330.0390.0320.0330.0120.0150.0170.020.0220.0330.0270.10.075
Reseach & Development Expenses 00000000000000000
General & Administrative Expenses 08.7846.1373.1944.2791.7343.1752.2471.5352.5842.3841.33907.87010.0266.317
Selling & Marketing Expenses 011.3253.8911.6182.0732.1642.947.1912.940.5088.2457.4710001.150.625
SG&A 85.49620.10910.0284.8126.3523.8976.1149.4394.4753.09218.76912.54107.87011.1766.942
Other Expenses 69.64974.3275.84845.8240.24922.3562.91681.83119.17327.0725.10818.60117.523.4923.244.7444.426
Operating Expenses 85.49689.627100.86763.73575.52268.32539.86391.26923.64727.0725.10818.60117.5211.3623.2415.9211.368
Operating Income 27.53366.92100.26582.30563.53891.29272.83779.78418.1314.113.419.0254.1119.9559.51111.457.328
Operating Income Ratio 0.0070.0160.020.0240.0210.0260.0210.020.0070.0070.0070.0050.0030.0150.020.0420.029
Total Other Income Expenses Net 25.896-6.8230.1060.7098.885-1.4329.07941.26511.7819.4224.634-6.931-7.093-1.276-0.011-0.2970
Income Before Tax 53.42960.151100.27183.01472.42489.8681.91679.78418.1314.113.419.0254.1119.9559.51111.457.328
Income Before Tax Ratio 0.0140.0150.020.0240.0240.0250.0230.020.0070.0070.0070.0050.0030.0150.020.0420.029
Income Tax Expense 6.59222.38634.82317.87114.48824.44220.1420.9665.2363.2162.92.4431.2732.051.4062.42.569
Net Income 46.83737.71165.54865.14357.93565.41861.77658.81812.89410.88410.516.5832.8397.9068.1059.054.759
Net Income Ratio 0.0120.0090.0130.0190.0190.0180.0180.0150.0050.0050.0050.0040.0020.0120.0170.0330.019
EPS 1.841.492.722.792.482.82.643.030.770.650.630.390.21.321.351.290.79
EPS Diluted 1.841.492.722.792.482.82.643.030.770.650.630.390.21.321.351.290.79
EBITDA 44.513104.56139.514115.46498.392121.366107.401102.10940.50436.9414.99621.73517.116.27414.19516.49111.754
EBITDA Ratio 0.0110.0250.0280.0330.0330.0340.0310.0260.0160.0170.0080.0130.0130.0240.0310.060.047